Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Receivables - Net: 2023-2025

Historic Receivables - Net for CG Oncology (CGON) over the last 2 years, with Sep 2025 value amounting to $515,000.

  • CG Oncology's Receivables - Net rose 275.91% to $515,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $515,000, marking a year-over-year increase of 275.91%. This contributed to the annual value of $92,000 for FY2023, which is N/A change from last year.
  • Per CG Oncology's latest filing, its Receivables - Net stood at $515,000 for Q3 2025, which was down 8.36% from $562,000 recorded in Q2 2025.
  • CG Oncology's Receivables - Net's 5-year high stood at $562,000 during Q2 2025, with a 5-year trough of $92,000 in Q4 2023.
  • Moreover, its 3-year median value for Receivables - Net was $182,000 (2024), whereas its average is $283,714.
  • Data for CG Oncology's Receivables - Net shows a peak YoY soared of 275.91% (in 2025) over the last 5 years.
  • Over the past 3 years, CG Oncology's Receivables - Net (Quarterly) stood at $92,000 in 2023, then reached $137,000 in 2024, then surged by 275.91% to $515,000 in 2025.
  • Its Receivables - Net was $515,000 in Q3 2025, compared to $562,000 in Q2 2025 and $345,000 in Q1 2025.